Bal Pharma (BPL) a member of the Mcro Laboratories group was incorporated as a private limited company in May '87. In Mar.'90 BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which BPL commenced manufacturing formulations.BPL manufactures and markets pharmaceutical formulations -- paracetamol aluminium hydroxide povidone iodine alprazolam gliclazide griseofulvin lactobacillus rifampicin piroxicam amoxycillin etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.During 1997-98 the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN CAFIMOL & CORTIDERM.The company has added further product range Zanovid Aziwin Dry Syrup Meloxi Ocium - M Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range the company has introduced Cardiac Specialities Products. To market these products a new division named SERVETUS has started functioning during 2001. New products like AmilorideBenzydamine and Ebastine were rolled into the market during 2002. |
Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 00:00 | 29 Jun | 96.55 |
-2.00 (-2.03%) |
OPEN
96.75 |
HIGH
97.05 |
LOW
96.20 |
NSE 00:00 | 29 Jun | 96.90 |
-1.80 (-1.82%) |
OPEN
97.80 |
HIGH
97.90 |
LOW
95.25 |
OPEN | 96.75 |
PREVIOUS CLOSE | 98.55 |
VOLUME | 2592 |
52-Week high | 148.50 |
52-Week low | 87.50 |
P/E | 17.52 |
Mkt Cap.(Rs cr) | 150 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Company History
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices